The current study presented that concentrations of selected serum substances such as CST, ChgA, NGF, and I-FABP, prohormones/hormones (IAPP, proIAPP), and other active substances (PAF) differ between T1D patients and healthy controls. This evidence concerns the gene CHGA and type 1 diabetes mellitus.